Followers | 505 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, December 14, 2014 10:18:47 AM
bullish
falling wedge breakout
$SGMO recent news/filings
## source: finance.yahoo.com
Fri, 12 Dec 2014 12:31:23 GMT ~ Sangamo Biosciences (SGMO) Jumps: Stock Rises 7.2%
read full: http://finance.yahoo.com/news/sangamo-biosciences-sgmo-jumps-stock-123123365.html
*********************************************************
Mon, 08 Dec 2014 12:35:16 GMT ~ Sangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad Application of ZFN Mediated Genome-Editing Approach to Therapeutics for Hemophilia and Lysosomal Storage Disorders
[at noodls] - December 8, 2014 Data Demonstrate Therapeutic Levels of Clotting Factor for Hemophilia in Non-Human Primates and In Vivo Protein Production of Lysosomal Storage Disease Enzymes RICHMOND, Calif., Dec. 8, ...
read full: http://www.noodls.com/view/33A671417680C5C572D3A7532CD47B589F985E81
*********************************************************
Mon, 08 Dec 2014 12:00:00 GMT ~ Sangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad Application of ZFN Mediated Genome-Editing Approach to Therapeutics for Hemophilia and Lysosomal Storage Disorders
[PR Newswire] - RICHMOND, Calif., Dec. 8, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (SGMO) announced the presentation of new preclinical data from its proprietary programs for the treatment of lysosomal storage disorders (LSD) and Shire-partnered hemophilia program. These studies demonstrate the broad applicability of Sangamo's In Vivo Protein Replacement Platform (IVPRP) for the potentially curative treatment of such diseases, and were presented at the 56th Annual Meeting of the American Society of Hematology (ASH) held in San Francisco from December 5 to 9, 2014. The data presented at ASH from Sangamo's proprietary IVPRP applications demonstrated the efficient production, secretion and tissue uptake of functional iduronate-2-sulfatase and alpha-L-iduronidase, enzymes that are deficient in the LSDs, Hunter and Hurler's disease, respectively. "These data provide proof of concept for this broadly applicable genome editing strategy. We demonstrate that our process can be applied to multiple gene targets and is scalable to large animals supporting the potential application of the albumin gene as a safe harbor site for expression of therapeutic proteins," said Philip Gregory, D. Phil., Sangamo's senior vice president of research and chief scientific officer.
read full: http://finance.yahoo.com/news/sangamo-biosciences-presents-data-american-120000279.html
*********************************************************
Wed, 19 Nov 2014 13:12:21 GMT ~ Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms
[at noodls] - RICHMOND, Calif., Nov. 19, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that positive preclinical data from its joint program with Shire plc, to develop a novel ZFP Therapeutic® ...
read full: http://www.noodls.com/view/DD2E3FA030BA9F90ACB07ED56711CBCC7A2B10EC
*********************************************************
Wed, 19 Nov 2014 12:00:00 GMT ~ Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms
[PR Newswire] - RICHMOND, Calif., Nov. 19, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that positive preclinical data from its joint program with Shire plc, to develop a novel ZFP Therapeutic ...
read full: http://finance.yahoo.com/news/sangamo-biosciences-presents-study-society-120000792.html
*********************************************************
$SGMO charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$SGMO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/SGMO/company-info
Ticker: $SGMO
OTC Market Place: Not Available
CIK code: 0001001233
Company name: Sangamo BioSciences, Inc.
Incorporated In: DE, USA
$SGMO share structure
## source: otcmarkets.com
Market Value: $1,130,717,674 a/o Dec 12, 2014
Shares Outstanding: 68,403,973 a/o Oct 22, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$SGMO extra dd links
Company name: Sangamo BioSciences, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=SGMO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=SGMO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=SGMO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/SGMO/news - http://finance.yahoo.com/q/h?s=SGMO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/SGMO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/SGMO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=SGMO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/SGMO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Sangamo+BioSciences%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Sangamo+BioSciences%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Sangamo+BioSciences%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/SGMO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001001233&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/SGMO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/SGMO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=SGMO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=SGMO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/SGMO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=SGMO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=SGMO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=SGMO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=SGMO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=SGMO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/SGMO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=SGMO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/SGMO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=SGMO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/SGMO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/SGMO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/SGMO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/SGMO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/SGMO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=SGMO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=SGMO
$SGMO DD Notes ~ http://www.ddnotesmaker.com/SGMO
Recent SGMO News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 07/08/2024 08:32:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:42:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:26:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:25:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:25:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:24:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:24:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:23:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:23:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:23:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 09:10:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 09:18:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 09:15:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 08:57:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 08:54:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:04:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:01:30 PM
- Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results • Business Wire • 05/09/2024 08:01:00 PM
- Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing • Business Wire • 05/09/2024 12:05:00 PM
- Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast • Business Wire • 05/02/2024 08:15:00 PM
- Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) • Business Wire • 04/22/2024 08:35:00 PM
- Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering • Business Wire • 03/22/2024 12:05:00 PM
- Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 03/13/2024 12:05:00 PM
- Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs • Business Wire • 03/13/2024 12:01:00 PM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM